Posts Tagged drug

Trump: Opioid Epidemic “Worst Drug Crisis” in U.S. History

Trump: Opioid Epidemic “Worst Drug Crisis” in U.S. History

President Trump called the opioid epidemic the “worst drug crisis” to strike the U.S. in its history while declaring a public health emergency – not a national emergency as promised earlier in the summer. According to the Centers for Disease Control and Prevention, more than 140 American die every day from an opioid overdose, which made President Trump’s announcement one of the most anticipated of the last few months yet not quite what health care advocates were expecting.

“Nobody has seen anything like this going on now. As Americans, we cannot allow this to continue,” Trump said at a White House ceremony. “It is time to liberate our communities from this scourge of drug addiction. … We can be the generation that ends the opioid epidemic. We can do it.”

There’s a legal distinction between a public health emergency, which the secretary of Health and Human Services can declare under the Public Health Services Act, and a presidential emergency under the Stafford Act or the National Emergencies Act. The President’s Opioid Commission recommended in July for a declaration of national emergency in order for the president to have more power to waive privacy laws and Medicaid regulations.

However, declaring a public health emergency, which can only last for 90 days and be renewed a number of times, demonstrates the complexity of an opioid crisis that continues to grow through an ever-evolving cycle of addiction, from prescription pain pills to illegal heroin to the lethality of fentanyl.

What the public health emergency won’t do is free up much federal funding. Acting Health and Human Services Secretary Eric Hargan will be given more room to loosen certain regulations that he otherwise would not be able to.

The declaration will expand access to telemedicine to better help those with an addiction in remote areas receive medications; allow for the shifting of resources within HIV/AIDS programs to help people eligible for those programs receive substance use disorder treatments; and more. It could spur a fight for funding in Congress, as Senate Democrats have introduced a bill to put $45 billion toward the epidemic. Many Republicans also back much more funding to combat the epidemic.

The opioid action is the first public health emergency with a nationwide scope since a year-long emergency to prepare for the H1N1 influenza virus in 2009 and 2010.

Posted in: Opioid

Leave a Comment (0) →

CDC Reports Rising Rates of Drug Overdose Deaths in Rural Areas

CDC Reports Rising Rates of Drug Overdose Deaths in Rural Areas

Rates of drug overdose deaths are rising in nonmetropolitan (rural) areas, surpassing rates in metropolitan (urban) areas, according to a new report in the Morbidity and Mortality Weekly Report (MMWR) released this week by the Centers for Disease Control and Prevention (CDC).

Drug overdoses are the leading cause of injury death in the United States, resulting in approximately 52,000 deaths in 2015. This report analyzed trends in illicit drug use and disorders from 2003-2014 and drug overdose deaths from 1999-2015 in urban and rural areas. In 1999, drug overdose death rates for urban areas were higher than in rural areas (6.4 per 100,000 population versus 4.0 per 100,000). The rates converged in 2004, and in 2006 the rural rate began trending higher than the urban rate. In 2015, the most recent year in this analysis, the rural rate of 17.0 per 100,000 remains slightly higher than the urban rate of 16.2 per 100,000.

Urban and rural areas experienced significant increases in the percentage of people reporting past-month illicit drug use. However, there were also significant declines in the percentage of people with drug use disorders among those reporting illicit drug use in the past year. The new findings also show an increase in overdose deaths between 1999 and 2015 among urban and rural residents. This increase was consistent across sex, race, and intent (unintentional, suicide, homicide, or undetermined).

“The drug overdose death rate in rural areas is higher than in urban areas,” said CDC Director Brenda Fitzgerald, M.D. “We need to understand why this is happening so that our work with states and communities can help stop illicit drug use and overdose deaths in America.”

Although the percentage of people reporting illicit drug use is less common in rural areas, the effects of use appear to be greater. The percentage of people with drug use disorders among those reporting past-year illicit drug use were similar in rural and urban areas.

Additional findings from the CDC study:

  • In 1999, drug overdose death rates for urban areas were higher than in rural areas (6.4 per 100,000 population versus 4.0 per 100,000). The rates converged in 2004, and by 2006 the rural rate (11.7 per 100,000) was slightly higher than the urban rate (11.5 per 100,000).
  • The percentage of people reporting past-month use of illicit drugs declined for youth ages 12-17 over a 10-year period but increased substantially in other age groups.
  • The percentage of people reporting past-month use of illicit drugs was higher for urban areas during the study period.
  • Among people reporting illicit drug use in the past year, drug use disorders decreased during the study period.
  • In 2015, approximately six times as many drug overdose deaths occurred in urban areas than in rural areas (urban: 45,059; rural: 7,345).

Most overdose deaths occurred in homes, where rescue efforts may fall to relatives who have limited knowledge of or access to life-saving treatment and overdose follow-up care. Considering where people live and where they die from overdose could improve interventions to prevent overdose. Understanding differences in illicit drug use, illicit drug use disorders, and drug overdose deaths in urban and rural areas can help public health professionals to identify, monitor, and prioritize responses.

Visit HHS’s Opioids website for more information on their 5-point strategy to combat the opioid crisis.

Visit CDC’s Opioid Overdose website for data, tools, and resources on opioid overdose prevention.

Visit CDC’s Rural Health website for more information on rural health topics.

Posted in: Opioid

Leave a Comment (0) →

Congress Squares Off Over Drug Pricing and a Controversial Drug Discount Program

Congress Squares Off Over Drug Pricing and a Controversial Drug Discount Program

House Democrats are calling foul on Republican assertions that cuts to a little-known discount drug program will eventually reduce skyrocketing drug prices. At a hearing Tuesday, Rep. Diana DeGette (D-Colo.) said high drug prices should be investigated separately from the focus on oversight of the drug discount program, known as 340B.

“I think we need an investigation, a robust investigation, and a series of hearings that explore in-depth the reasons for the exorbitant cost of drugs and why the prices continue to rise,” DeGette said.

Last week, Health and Human Services Secretary Tom Price proposed steep cuts in what Medicare reimburses some hospitals for outpatient drugs under the 340B program. In a release, Price said such cuts would be “a significant step toward fulfilling President [Donald] Trump’s promise to address rising drug prices.”

DeGette countered Tuesday that the proposal “would do nothing” to address high drug prices and said making that connection “seems more like fantasy than reality.”

Also on Tuesday, there were other hints at Trump administration efforts to address drug pricing. Food and Drug Administration Commissioner Scott Gottlieb talked in a public meeting about lowering drug prices on a different front — saying that the agency needs to increase generic-drug competition.

Trump routinely criticized high drug prices on the campaign trail last year and promised to take action during his presidency. In June, a leaked draft of an executive order on drug prices, first reported by The New York Times, spoke of facilitating more drug competition but also targeted the 340B program. That strategy immediately drew criticism from Sen. Al Franken (D-Minn.), who said scaling back the program would drive up what hospital patients pay for drugs and force Americans “to choose between health and other basic life necessities, like putting food on the table and a roof overhead for the family.”

The federal 340B program requires pharmaceutical manufacturers to provide outpatient drugs at a significant discount to hospitals and clinics that serve a largely low-income population.

After buying the discounted drugs, the hospitals and clinics can bill Medicare or other insurers at their regular rate, pocketing the difference.

About 40 percent of hospitals nationwide participate in the program and, as House members pointed out Tuesday, the program has grown dramatically in recent years to become a significant force in the pharmaceutical marketplace. The Medicare Payment Advisory Commission estimated that hospitals and other participating entities spent more than $7 billion to buy 340B drugs in 2013, three times the amount spent in 2005.

Advocates of the program say the discounts — and the money hospitals make on payments from Medicare — are necessary to combat skyrocketing drug prices.

But federal reports in recent years from the Medicare advisory board, as well as the Government Accountability Office and the Office of Inspector General, have raised concerns about oversight and abuse of the 340B program.

Rep. Joe Barton (R-Texas) noted “this is a difficult hearing” because while the program was created with good intent, its complexity makes it challenging to understand. For example, hospitals and clinics aren’t required to pass any discounts they receive on to patients — they can direct the money to their general fund.

Looking at his colleagues, Barton said: “We all support the program but it has grown topsy-turvy. We need to put the best minds on this.”

Republican lawmakers are not the only ones raising concerns about 340B oversight. The Pharmaceutical Research and Manufacturers of America, which represents drugmakers, advocates ensuring hospitals are “good stewards” of the money they gain from the program’s discounts.

Peggy Tighe, who represents hospitals in the 340B program as a principal at the D.C. law firm Powers, said “PhRMA has done a particularly good job of getting the attention of the administration. … They haven’t let up on 340B.”

The rule that Price proposed last week would cut what hospitals are paid for drugs from the Medicare Part B program, which covers outpatient drugs including those delivered through infusion.

Currently, Medicare pays hospitals an average sales price plus 6 percent for most of the Part B drugs they purchase. The administration’s proposal is to cut that to average sales price minus 22.5 percent.

340B Health, a coalition that represents hospitals, immediately responded to the proposal saying the cuts would be “devastating” to hospitals and would “lead to cuts in patient services.”

 

sjtribble@kff.org | @SJTribble | Kaiser Health News, a nonprofit health newsroom whose stories appear in news outlets nationwide, is an editorially independent part of the Kaiser Family Foundation. KHN’s coverage of prescription drug development, costs and pricing are supported in part by the Laura and John Arnold Foundation.

Posted in: Advocacy

Leave a Comment (0) →

Public Restrooms Become Ground Zero in the Opioid Epidemic

Public Restrooms Become Ground Zero in the Opioid Epidemic

A man named Eddie threaded through the midafternoon crowd in Cambridge, Mass. He was headed for a sandwich shop, the first stop on a tour of public bathrooms.

“I know all the bathrooms that I can and can’t get high in,” said Eddie, 39, pausing in front of the shop’s plate-glass windows, through which we can see a bathroom door.

Eddie, whose last name we’re not including because he uses illegal drugs, knows which restrooms along busy Massachusetts Avenue he can enter, at what hours and for how long. Several restaurants, offices and a social services agency in this neighborhood have closed their restrooms in recent months, but not this sandwich shop.

“With these bathrooms here, you don’t need a key. If it’s vacant, you go in. And then the staff just leaves you alone,” Eddie said. “I know so many people who get high here.”

At the fast-food place right across the street, it’s much harder to get in and out.

“You don’t need a key, but they have a security guard that sits at the little table by the door, directly in front of the bathroom,” Eddie said. Some guards require a receipt for admission to the bathroom, he said, but you can always grab one from the trash.

A chain restaurant a few stores down has installed bathroom door locks opened by a code that you get at the counter. But Eddie and his friends just wait by the door until a customer goes into the restroom, then grab the door and enter as the customer leaves.

“For every 10 steps they use to safeguard against us doing something, we’re going to find 15 more to get over on their 10. That’s just how it is. I’m not saying that’s right, that’s just how it is,” Eddie said.

Eddie is homeless and works at a restaurant. Public bathrooms are among the few places where he can find privacy to inject heroin. He says he doesn’t use the drug often these days. Eddie is on methadone, which curbs his craving for heroin, and he says he now uses the drug only occasionally to be social with friends.

He understands why restaurant owners are unnerved.

“These businesses, primarily, are like family businesses; middle-class people coming in to grab a burger or a cup of coffee. They don’t expect to find somebody dead,” Eddie said. “I get it.”

Managing Public Bathrooms Is ‘A Tricky Thing’

Many businesses don’t know what to do. Some have installed low lighting — blue light, in particular — to make it difficult for people who use injected drugs to find a vein.

The bathrooms at 1369 Coffee House, in the Central Square neighborhood of Cambridge, are open for customers who request the key code from staff at the counter. The owner, Joshua Gerber, has done some remodeling to make the bathrooms safer. There’s a metal box in the wall next to his toilet for needles and other things that clog pipes. And Gerber removed the dropped ceilings in his bathrooms after noticing things tucked above the tiles.

“We’d find needles or people’s drugs,” Gerber said. “It’s a tricky thing, managing a public restroom in a big, busy square like Central Square where there’s a lot of drug use.”

Gerber and his staff have found several people on the bathroom floor in recent years, not breathing.

“It’s very scary,” Gerber said. His eyes drop briefly. “In an ideal world, users would have safe places to go [where] it didn’t become the job of a business to manage that and to look after them and make sure that they were OK.”

There are such public safe-use places in Canada and some European countries, but not in the U.S., at least not yet. So Gerber is taking the unusual step of training his baristas to use naloxone, the drug that reverses most opioid overdoses. He sent a training invitation email to all employees recently. Within 10 minutes, he had about 25 replies.

“Mostly capital ‘Yes!! I’ll be there for sure!’ ‘Count me in!’” Gerber recalled with a grin. “You know, [they were] just thrilled to figure out how they might be able to save a life.”

Safe Spaces and Hospital Bathrooms

Last fall, a woman overdosed in a bathroom in the main lobby of Massachusetts General Hospital in Boston. Luckily, naloxone has become standard equipment for security guards at many hospitals in the Boston area, including that one.

“I carry it on me every day, it’s right here in a little pouch,” said Ryan Curran, a police and security operations manager at the hospital, pulling a small black bag out of his suit jacket pocket.

The woman who overdosed survived, as have seven or eight people who overdosed in the bathrooms since Curran’s team started carrying naloxone in the past 12 to 18 months.

“It’s definitely relieving when you see someone breathing again when two, three minutes beforehand they looked lifeless,” Curran said. “A couple of pumps of the nasal spray and they’re doing better. It’s pretty incredible.”

Massachusetts General Hospital began training security guards after emergency room physician Dr. Ali Raja realized that the hospital’s bathrooms had become a haven for some of his overdose patients.

“There’s an understanding that if you overdose in and around a hospital that you’re much more likely to be able to be treated,” Raja said, “and so we’re finding patients in our restrooms, we’re finding patients in our lobbies who are shooting up or taking their prescription pain medications.”

Many businesses, including hospitals and clinics, don’t want to talk about overdoses within their buildings. Curran wants to be sure the hospital’s message about drug use is clear.

“We don’t want to promote, obviously, people coming here and using it, but if it’s going to happen, then we’d like to be prepared to help them and save them and get them to the [Emergency Department] as fast as possible,” Curran said.

Speed is critical, especially now, when heroin is routinely mixed with the much more potent opioid, fentanyl. Some clinics and restaurants check on bathroom users by having staff knock on the door after 10 or 15 minutes, but fentanyl can deprive the brain of oxygen and cause death within that window. One clinic has installed an intercom and requires people to respond. Another has designed a reverse-motion detector that sets off an alarm if there’s no movement in the bathroom.

Limited Public Discussion

There’s very little discussion of the problem in public, says Dr. Alex Walley, director of the Addiction Medicine Fellowship Program at Boston Medical Center.

“It’s against federal and state law to provide a space where people can use [illegal drugs] knowingly, so that is a big deterrent from people talking about this problem,” he said.

Without some guidance, more libraries, town halls and businesses are closing their bathrooms to the public. That means more drug use, injuries and discarded needles in parks and on city streets.

In the area around Boston Medical Center, wholesalers, gas station owners and industrial facilities are looking into renting portable bathrooms.

“They’re very concerned for their businesses,” said Sue Sullivan, director of the Newmarket Business Association, which represents 235 companies and 28,000 employees in Boston. “But they don’t want to just move the problem. They want to solve the problem.”

Walley and other physicians who work with addiction patients say there are lots of ways to make bathrooms safer for the public and for drug users. A model restroom would be clean and well-lit with stainless-steel surfaces, and few cracks and crevices for hiding drug paraphernalia. It would have a biohazard box for needles and bloodied swabs. It would be stocked with naloxone and perhaps sterile water. The door would open out so that a collapsed body would not block entry. It would be easy to unlock from the outside. And it would be monitored, preferably by a nurse or EMT.

There are Very Few Bathrooms that Fit this Model in the U.S.

Some doctors, nurses and public health workers who help addiction patients argue any solution to the opioid crisis will need to include safe injection sites, where drug users can get high with medical supervision.

“There are limits to better bathroom management,” said Daniel Raymond, deputy director for policy and planning at the New York-based Harm Reduction Coalition. If communities like Boston start to reach a breaking point with bathrooms, “having dedicated facilities like safer drug consumption spaces is the best bet for a long-term structural solution that I think a lot of business owners could buy into.”

Maybe. No business groups in Massachusetts have come out in support of such spaces yet.

By Martha Bebinger, WBUR | This story is part of a partnership that includes WBUR, NPR and Kaiser Health News. Kaiser Health News, a nonprofit health newsroom whose stories appear in news outlets nationwide, is an editorially independent part of the Kaiser Family Foundation.

Posted in: Health

Leave a Comment (0) →

STUDY: Opioid Abuse Drops When Doctors Check Patients’ Drug History

STUDY: Opioid Abuse Drops When Doctors Check Patients’ Drug History

ITHACA, N.Y. – There’s a simple way to reduce the opioid epidemic gripping the country, according to new Cornell University research: Make doctors check their patients’ previous prescriptions.

The most significant response to the opioid epidemic comes from state governments. Nearly every state now has a database that tracks every prescription for opioids like OxyContin, Percocet and Vicodin. Using these databases, doctors and pharmacists can retrieve a patient’s history to decide whether they are an opioid abuser before prescribing them drugs.

Such databases reduce opioid abuse among Medicare recipients – but only when laws require doctors to consult them, according to a Cornell health care economist and her colleague. Their study refutes previous research suggesting the databases have no effect on opioid abuse. The paper is forthcoming in the American Economic Journal: Economic Policy.

“The main issue is getting providers to change their prescribing behavior. The majority of opioids that people abuse start in the medical system as a legitimate prescription,” said co-author Colleen Carey, assistant professor of policy analysis and management in the College of Human Ecology. Her co-author is Thomas Buchmueller of the University of Michigan.

States that implemented a “must access” database saw a decline in the number of Medicare recipients who got more than a seven-months’ supply in a six-month period. And there was a decrease in those who filled a prescription before the previous prescription’s supply had been used.

“Doctor shopping” also dropped. Medicare opioid users who got prescriptions from five or more doctors – a common marker for “doctor shopping” – fell by 8 percent; the number of those who got opioids from five or more pharmacies declined by more than 15 percent.

On the flip side, Medicare patients appeared to evade the new regulations by traveling to a less-regulated state.

Although the study looked only at Medicare recipients, the findings are likely to translate to the general population, the researchers said. The effects were especially large for low-income disabled users and for those who obtain opioid prescriptions from a high number of doctors; both groups have the highest rates of misuse and abuse, Carey said.

The strongest effects were in states with the strictest laws, such as New York, which require doctors to check the opioid history of “every patient, every time.” But even states with laws requiring access only under certain circumstances reduced doctor shopping.

Until recently Medicare has had very few legislative tools to curtail the epidemic. And insurance companies have little incentive, because opioids are relatively cheap, costing about $1.60 per day in the study’s sample. And opioids don’t hit Medicare insurers in the bottom line, making up only 3 percent of their total drug costs, Carey said.

For information about the Medical Association prescription drug abuse awareness program, visit Smart & Safe.

Posted in: Smart and Safe

Leave a Comment (0) →

Medical Association Joins AMA for Release of Opioid Education and Resource Toolbox

Medical Association Joins AMA for Release of Opioid Education and Resource Toolbox

BIRMINGHAM – The Medical Association and the American Medical Association partnered in the development and release of a toolbox of data, education and other resources to aid physicians in their continued fight against Alabama’s epidemic of prescription drug misuse, overdose and death. The toolbox was released in a press conference during the Association’s November Opioid Prescribing Education conference in Birmingham.

This toolbox is part of the Medical Association’s continuing efforts – legislative and other – to reverse this epidemic, and Alabama is one of two states participating in this pilot program.

“Although Alabama is no longer the top prescriber of opioids in the country, we still have a very long way to go as far as educating our physicians and other prescribers how to properly handle the prescription of opioid pain medication and those patients that require that medication,” said Medical Association Executive Director Mark Jackson. “This toolbox will help physicians not only educate patients about pain, but also provide resources for overdose prevention and treatment.”

Jackson said he hopes Alabama’s physicians will find the toolbox useful and help strengthen their physician-patient relationships as they continue to discuss pain-related issues with their patients.

“This toolbox contains the types of data and resources that physicians can rely on to help improve their practices for their patients,” said Gerald Harmon, M.D., chair-elect of the American Medical Association Board of Trustees, who also spoke at the press conference. “We recognize that we have much more to accomplish, but physicians in Alabama and across the nation already have made important strides to reverse the nation’s opioid epidemic, and using these resources will help physicians continue that progress.”

Alabama, along with Rhode Island, are the only two states in this grant. These states were chosen due to many factors, including high rates of opioid-related harm as well as diverse demographic, socioeconomic, geographic and other characteristics. The characteristics offer excellent opportunities to study the implementation of the toolbox, refine it, and potentially use it as a model for other states that want to undertake similar efforts.

The toolbox can be viewed online at www.SmartAndSafeAL.org/physicians.

Funding for this initiative was made possible (in part) by Providers’ Clinical Support System for Opioid Therapies (grant no. 5H79TI025595) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Posted in: Smart and Safe

Leave a Comment (0) →

Alabama Physicians Partner with the AMA to Combat Opioid Epidemic

Alabama Physicians Partner with the AMA to Combat Opioid Epidemic

Pilot Program Designed to Reduce Prescription Opioid Misuse and Heroin Use

MONTGOMERY | Aug. 10, 2016 – The Medical Association of the State of Alabama and the American Medical Association announced today a partnership to develop and distribute a statewide educational toolbox designed to help reverse the state’s opioid epidemic. Alabama and Rhode Island are the first two states partnering in this pilot program with the AMA.

“To bring a halt to this devastating opioid epidemic, physicians must remain committed to leading this fight – to enhancing their education and to using all tools at their disposal to help treat patients with pain and opioid use disorders as well as ensuring comprehensive treatment with non-pharmacologic therapies when appropriate,” said Patrice A. Harris, M.D., the chair of the AMA Board of Trustees and the chair of the AMA’s Task Force to Reduce Opioid Abuse.

In 2013, the Medical Association of the State of Alabama helped pass legislation to reduce prescription drug abuse and diversion. That legislation resulted in Alabama having the largest decrease in the Southeast – the third-largest in the nation regarding the use of the most highly addictive prescription drugs.

“Alabama’s physicians recognize we have a serious prescription drug problem in our state,” said Medical Association President David Herrick, M.D., of Montgomery. “We have made great strides in providing better education on the dangers of prescription drug abuse to our fellow physicians and to our patients through our Smart & Safe drug abuse awareness campaign. But there is much more work to be done. Partnering with the American Medical Association will help us to bring even more awareness as we fight Alabama’s prescription drug abuse epidemic together.”

The pilot program will build a toolbox – available online and in print – that incorporates the best information from the AMA, the Medical Association and Alabama’s health officials. It will be provided to physicians and other health care professionals with key data, valuable resources, and practice-specific recommendations they need to enhance their decision-making when caring for patients suffering from chronic or acute pain and opioid use disorders, as well as for patients needing overdose prevention education.

The toolbox will be released in September, and the Medical Association and the AMA and will work together to distribute it throughout Alabama.

The AMA was awarded funding through the Prescriber Clinical Support System for Opioid Therapies, funded by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) and administered by the American Academy of Addiction Psychiatry.

Posted in: Smart and Safe

Leave a Comment (0) →
Page 2 of 2 12